Organisational Information
Papers & Reports
The latest reports, papers, and submissions from Children by Choice.
Access to Care
Systemic delays to abortion access undermine the health and rights of abortion seekers across Australia.
Aust N Z J Obstet Gynaecol 2023; 63: 612–615.
Submission to the Universal Access to Reproductive Healthcare Senate Inquiry
Submission to the Senate Community Affairs References Committee’s Inquiry into Universal Access to Reproductive Healthcare 2022.
Review of termination of pregnancy laws
Children by Choice submission to the Queensland Law Reform Commission, supporting the decriminalisation of abortion, January 2018.
Additional
A Compilation of Termination of Pregnancy Request Data.
Children by Choice received a grant from Queensland Health to complete 16 individual Hospital and Health Service reports based on data from 2016/18.
Ulipristal availability in Australia.
Children by Choice submission to the Therapeutic Goods Administration supporting over the counter provision of ulipritsal (emergency contraception), April 2016.
The Cost of Abortion Access in Queensland
Data from the Children by Choice financial assistance program for disadvantaged women 2015 -2017.
A Human Rights Act for Queensland.
Children by Choice submission to Queensland government, March 2016.
Developing a Queensland Women’s Strategy.
Children by Choice submission to Queensland government, December 2015.
Over the counter oral contraceptive provision.
Children by Choice submission to the Therapeutic Goods Administration on creating Schedule 3 entries for oral contraception, December 2014.
Out-of-pocket costs in Australian healthcare.
Children by Choice submission to the federal Community Affairs Reference committee, May 2014.
Submission by Children by Choice to the Senate Standing Committee
on Finance and Public Administration.
Inquiry into Health Insurance Amendment (Medicare Funding for
Certain Types of Abortion) Bill 2013.
Submission to Pharmaceutical Benefits Advisory Committee.
For consideration at the March 2013 PBAC Meeting.
Submission by Children by Choice in support of the listing on the PharmaceuticalBenefits Scheme of the drug MIFEPRISTONE (200 mg tablet Mifepristone Linepharma®); and MISOPROSTOL, (200 microgram tablet, GyMiso®) for medical termination of a developing intra-uterine pregnancy.
Queensland Child Protection Commission of Inquiry.
Children by Choice submission, September 2012.
National Women’s Health Policy development.
Submission, November 2009.
Abortion Law and Policy
Equity and Inclusion
Setting the Agenda
Children by Choice submission to the Australian Labor Party's national consultation on gender equity, August 2017.
Additional
Expansion of income management submission.
Children by Choice submission to the federal Government, June 2010.
Violence & Control
Reproductive Coercion and Abuse among clients with disabilities of an Australian pregnancy options counselling service
Research paper, December 2022
Children by Choice X WWILD Collaboration
Pregnancy decision-making support for pregnant people with intellectual and learning disability experiencing reproductive coercion and abuse.
Reproductive coercion and abuse among pregnancy counselling clients in Australia: trends and directions
Research paper published July 2022.
Additional
Domestic violence in Australia
Reproductive Coercion White Paper Development
Children by Choice submission to Marie Stopes Australia white paper development process, February 2014.
